{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:41:56Z","timestamp":1790383316263,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jddst.2023.104486","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T06:49:30Z","timestamp":1681973370000},"page":"104486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study"],"prefix":"10.1016","volume":"84","author":[{"given":"Hamid Reza","family":"Samaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohar","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnar","family":"Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-9961","authenticated-orcid":false,"given":"Majid","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Davoudi Badabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Asare-Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-2482","authenticated-orcid":false,"given":"Ali","family":"Nokhodchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Roozbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Moosazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-7749","authenticated-orcid":false,"given":"Roya","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jddst.2023.104486_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cmi.2020.04.023","article-title":"COVID-19 pandemic A focused review for clinicians","volume":"26","author":"Cevik","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jddst.2023.104486_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152302","article-title":"A review on structural, non-structural, and accessory proteins of SARS-CoV-2: highlighting drug target sites","volume":"228","author":"Jahirul Islam","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.jddst.2023.104486_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jddst.2023.104486_bib4","first-page":"369","article-title":"Recent developments in the immunopathology of COVID-19, REVIEW","volume":"78","author":"Zhang","year":"2023","journal-title":"EAACI"},{"key":"10.1016\/j.jddst.2023.104486_bib5","article-title":"Bacterial and viral infections among adults hospitalized with COVID-19","volume":"17","author":"Shah","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jddst.2023.104486_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12890-023-02315-9","article-title":"Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome","volume":"20","author":"Iacovelli","year":"2023","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jddst.2023.104486_bib7","series-title":"Clin Microbiol Infect","first-page":"125","article-title":"Bacteriophage therapy in humans","author":"Nir-Paz","year":"2023"},{"key":"10.1016\/j.jddst.2023.104486_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/v15020588","article-title":"Phage therapy in Germany-update 2023","volume":"15","author":"Willy","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jddst.2023.104486_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2021.11.001","article-title":"Phage therapy for secondary bacterial infections with COVID-19","volume":"52","author":"Nannan","year":"2022","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jddst.2023.104486_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95132-1","article-title":"Encapsulation of bacteriophage cocktail into chitosan for the treatment of bacterial diarrhea","volume":"11","author":"Rahimzadeh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jddst.2023.104486_bib11","first-page":"290","article-title":"Ultra structural characteristics of methicillin resistant Staphylococcus aureus cell wall after affecting with lytic bacteriophages using atomic force microscopy","volume":"22","author":"Rahimzadeh","year":"2019","journal-title":"IJBMS"},{"key":"10.1016\/j.jddst.2023.104486_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1656(99)00185-6","article-title":"Endotoxin removal from protein solutions","volume":"76","author":"Putsch","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jddst.2023.104486_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21767\/AMJ.2016.2642","article-title":"Characterization and lytic activity of methicillin-resistant Staphylococcus aureus (MRSA) phages isolated from NICU","volume":"9","author":"Rahimzadeh","year":"2016","journal-title":"Australas. Med. J."},{"key":"10.1016\/j.jddst.2023.104486_bib14","article-title":"Characterization of methicillin-resistant Staphylococcus aureus (MRSA) phages from sewage at a tertiary pediatric hospital","volume":"5","author":"Rahimzadeh","year":"2017","journal-title":"Arch Pediatr Infect Dis"},{"key":"10.1016\/j.jddst.2023.104486_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00253-009-2386-9","article-title":"Antibacterial and biofilm removal activity of a Podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme","volume":"86","author":"Son","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jddst.2023.104486_bib16","first-page":"72","article-title":"Application of bacteriophage cocktail to control multi-drug resistant Pseudomonas aeruginosa","volume":"9","author":"The Tai","year":"2021","journal-title":"J Microbiol Exp"},{"key":"10.1016\/j.jddst.2023.104486_bib17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/antibiotics10081000","article-title":"Gram-positive pneumonia: possibilities offered by phage therapy","volume":"10","author":"Fern\u00e1ndez","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jddst.2023.104486_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41479-021-00083-w","article-title":"The role of co-infections and secondary infections in patients with COVID-19","volume":"25","author":"Feldman","year":"2021","journal-title":"Pneumonia"},{"key":"10.1016\/j.jddst.2023.104486_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.micinf.2020.05.007","article-title":"Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"22","author":"Lv","year":"2020","journal-title":"Microb. Infect."},{"key":"10.1016\/j.jddst.2023.104486_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104364","article-title":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","volume":"127","author":"Zhang","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jddst.2023.104486_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/v9030050","article-title":"A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms","volume":"18","author":"Doss","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jddst.2023.104486_bib22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1086\/651135","article-title":"Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections","volume":"201","author":"Debarbieux","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jddst.2023.104486_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0169-z","article-title":"The disparate effects of bacteriophages on antibiotic-resistant bacteria","volume":"7","author":"Torres-Barcel\u00f3","year":"2018","journal-title":"Emerg. microbes & infect."},{"key":"10.1016\/j.jddst.2023.104486_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.36348\/sb.2021.v07i03.003","article-title":"Bacteriophage therapy: recent development and applications","volume":"7","author":"Raza","year":"2021","journal-title":"Sch Bull"},{"key":"10.1016\/j.jddst.2023.104486_bib25","article-title":"Phage therapy of pulmonary infections","volume":"5","author":"Abaddon","year":"2015","journal-title":"Bacteriophage"},{"key":"10.1016\/j.jddst.2023.104486_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"},{"key":"10.1016\/j.jddst.2023.104486_bib27","article-title":"Prophylaxis of Mycobacterium tuberculosis H37Rv infection in a preclinical mouse model via inhalation of nebulized bacteriophage D29","volume":"63","author":"Nicholas","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jddst.2023.104486_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019527","article-title":"Phage therapy against Streptococcus pneumoniae: modern tool to control pneumonia","volume":"27","author":"Qadir","year":"2017","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.jddst.2023.104486_bib29","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus: an experimental study in rats","volume":"225","author":"Josef Praza","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jddst.2023.104486_bib30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.jddst.2023.104486_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-19","article-title":"Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice","volume":"63","author":"Dufour","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jddst.2023.104486_bib32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.jddst.2023.104486_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem-resistant acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jddst.2023.104486_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1751-7915.2011.00259.x","article-title":"Evaluation of lytic activity of staphylococcal bacteriophage Sb\u20101 against freshly isolated clinical pathogens","volume":"4","author":"Kvachadze","year":"2011","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jddst.2023.104486_bib35","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3389\/fmicb.2017.02659","article-title":"Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice","volume":"8","author":"Hua","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jddst.2023.104486_bib36","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.2147\/IDR.S326230","article-title":"Evaluation of phage therapy for pulmonary infection of mouse by liquid aerosol-exposure Pseudomonas aeruginosa","volume":"14","author":"Yajun","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jddst.2023.104486_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jamp.2015.1233","article-title":"Inhalation study of mycobacteriophage D29 aerosol for mice by endotracheal route and nose-only exposure","volume":"29","author":"Liu","year":"2016","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jddst.2023.104486_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections","volume":"133","author":"Chang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224723003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224723003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:52:28Z","timestamp":1761713548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224723003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S1773224723003386"],"URL":"https:\/\/doi.org\/10.1016\/j.jddst.2023.104486","relation":{},"ISSN":["1773-2247"],"issn-type":[{"value":"1773-2247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jddst.2023.104486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104486"}}